IL6 and Granuloma: Beyond its Th17-suppressive and skin-barrier-restorative activities, tapinarof directly dampens LL-37-induced mast-cell degranulation, down-regulating chymase-1, tryptase-β, MMP-9, TNF-α and IL-6—mediators implicated in granuloma formation.4